Clinical Trial Update: Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating two doses of an oral live attenuated HRV rotavirus vaccine for the prophylaxis of rotavirus gastroenteritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infections

Drugs mentioned

• HRV vaccine (Rhesus Rotavirus Vaccine, Live) (Rhesus Rotavirus Vaccine, Live)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED